Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL

NCT04175587 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukaemia

Interventions

DRUG: Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid

Sponsor

Peking University People's Hospital

Collaborators

[object Object]